LAB Stock Overview
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide.
Standard BioTools Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$1.23|
|52 Week High||US$6.67|
|52 Week Low||US$1.15|
|1 Month Change||-12.14%|
|3 Month Change||-31.67%|
|1 Year Change||-81.36%|
|3 Year Change||-73.89%|
|5 Year Change||-75.60%|
|Change since IPO||-91.23%|
Recent News & Updates
|LAB||US Life Sciences||US Market|
Return vs Industry: LAB underperformed the US Life Sciences industry which returned -35.1% over the past year.
Return vs Market: LAB underperformed the US Market which returned -23% over the past year.
|LAB Average Weekly Movement||12.0%|
|Life Sciences Industry Average Movement||9.7%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.8%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: LAB is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: LAB's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system.
Standard BioTools Inc. Fundamentals Summary
|LAB fundamental statistics|
Is LAB overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LAB income statement (TTM)|
|Cost of Revenue||US$97.17m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-2.07|
|Net Profit Margin||-145.56%|
How did LAB perform over the long term?See historical performance and comparison